• Home
  • Study Details
By physician referral or invitation only

APT-1011 (Fluticasone ODT) Expanded Access Protocol

The purpose of this program is to provide compassionate use of APT-1011 for adult and adolescent patients with eosinophilic esophagitis (EoE) who are unable or ineligible to enroll in an APT-1011 clinical study or have failed available treatment options

Age & Gender

  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Evan Dellon
Medicine-Gastroenterology

Study Type

Clinical or Medical
Interventional

Study Topics

Chronic Conditions
Stomach, Digestion and Gut Health

IRB Number

22-1095

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research